# Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy Surgery

> **NCT00877799** · PHASE2 · COMPLETED · sponsor: **Cara Therapeutics, Inc.** · enrollment: 114 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** CR845
- **DRUG:** CR845
- **DRUG:** CR845
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00877799
- **Lead sponsor:** Cara Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-12
- **Final completion:** 2010-01
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2015-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00877799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00877799, "Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00877799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*